Biotech

11 Children Regain Sight Thanks to MeiraGTx

The leading gene therapy company, has announced positive clinical trial results for its groundbreaking gene therapy treatment aimed at restoring vision in children with inherited retinal diseases

Kadimastem Renews Push for Nasdaq Listing

Kadimastem has secured shareholder approval for a merger with NLS Pharmaceutics, aiming to achieve a Nasdaq listing and advance its cell therapy treatments for amyotrophic lateral sclerosis (ALS).

IGM Biosciences Halts Lead Autoimmune Programs, Cuts Workforce by 73%

IGM Biosciences is discontinuing its lead autoimmune programs, imvotamab and IGM-2644, following disappointing clinical results, and implementing a 73% workforce reduction while reevaluating its strategic direction.

Verdiva Bio Launches with $411M Funding to Revolutionize Obesity and Cardiometabolic Care

Biotech Startup Unveils Next-Generation Therapies, Including a Promising Once-Weekly Oral GLP-1 Peptide, Backed by Leading Global Investors.

The Four Powerhouses of DNA Sequencing

Dive into the leading DNA sequencing technologies driving genomic discovery from Oxford Nanopore, Illumina, PacBio, and 10x Genomics.

AbbVie Expands Immunology Pipeline with Acquisition of Nimble Therapeutics and Aliada Therapeutics

AbbVie has bolstered its immunology and immuno-oncology portfolios by acquiring Nimble Therapeutics and Aliada Therapeutics, key players in preciscion medicine and cancer immune modulation.